This article is more than 5 years old. Information may no longer be current.

VIDEO: Tumor size, node status, age affect risk for breast cancer mortality

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — At the ASCO Annual Meeting, Jose Pablo Leone, MD, medical oncologist at Dana-Farber Cancer Institute, spoke with HemOnc Today about a study that assessed contributing factors for breast cancer-specific mortality over a period of 20 years.

The study revealed that larger tumor size, higher node status, older and younger age and higher tumor grade were markedly associated with breast cancer mortality, Leone said.

The risk for breast cancer-specific mortality was five times less likely than the risk for death from other causes in patients with early-stage breast cancer, according to Leone. Conversely, patients with later-stage breast cancer were twice as likely to die from breast cancer than other causes.

These results have the potential to aid in intervention recommendations after breast cancer is diagnosed, he said. – by Alaina Tedesco

Reference:

Leone JP, et al. Abstract 540. Presented at: ASCO Annual Meeting; May 31-June 4, 2019; Chicago.

Disclosure: Leone reports receiving research funding from Eli Lilly and Company, Kazia Therapeutics, Merck Sharp & Dohme and Seattle Genetics.